Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Herrick

Showing results (1-10 of 415) with videos related to

Pageof 42
Sort By:
British Journal of Rheumatology|November 1, 1995
Neurological involvement in systemic sclerosisA L Herrick
Current Opinion in Rheumatology|November 25, 2000
Vascular function in systemic sclerosisA L Herrick
Current Rheumatology Reports|January 8, 2013
Management of Raynaud's phenomenon and digital ischemiaAriane L Herrick
Journal of Scleroderma and Related Disorders|April 6, 2022
Raynaud's phenomenonAriane L Herrick
Current Opinion in Rheumatology|September 3, 2011
Contemporary management of Raynaud's phenomenon and digital ischaemic complicationsAriane L Herrick
Expert Review of Clinical Immunology|January 17, 2017
Therapeutic implications from the pathogenesis of Raynaud's phenomenonAriane L Herrick
Lancet (London, England)|December 24, 1998
Advances in treatment of systemic sclerosisA L Herrick
Current Opinion in Rheumatology|November 1, 1996
Advances in palliative care for the patient with sclerodermaA L Herrick
Rheumatology (Oxford, England)|February 14, 2026
Assessing digital vasculopathy in systemic sclerosisAriane L Herrick
Expert Opinion on Investigational Drugs|January 5, 2002
Development of agents for the treatment of systemic sclerosisA L Herrick
Pageof 42

Showing results (1-10 of 415) with videos related to

Sort By:
Pageof 42
British Journal of Rheumatology|November 1, 1995
Neurological involvement in systemic sclerosisA L Herrick
Current Opinion in Rheumatology|November 25, 2000
Vascular function in systemic sclerosisA L Herrick
Current Rheumatology Reports|January 8, 2013
Management of Raynaud's phenomenon and digital ischemiaAriane L Herrick
Journal of Scleroderma and Related Disorders|April 6, 2022
Raynaud's phenomenonAriane L Herrick
Current Opinion in Rheumatology|September 3, 2011
Contemporary management of Raynaud's phenomenon and digital ischaemic complicationsAriane L Herrick
Expert Review of Clinical Immunology|January 17, 2017
Therapeutic implications from the pathogenesis of Raynaud's phenomenonAriane L Herrick
Lancet (London, England)|December 24, 1998
Advances in treatment of systemic sclerosisA L Herrick
Current Opinion in Rheumatology|November 1, 1996
Advances in palliative care for the patient with sclerodermaA L Herrick
Rheumatology (Oxford, England)|February 14, 2026
Assessing digital vasculopathy in systemic sclerosisAriane L Herrick
Expert Opinion on Investigational Drugs|January 5, 2002
Development of agents for the treatment of systemic sclerosisA L Herrick
Pageof 42